A Human Papillomavirus (HPV) In Vitro Neutralization Assay That Recapitulates the In Vitro Process of Infection Provides a Sensitive Measure of HPV L2 Infection-Inhibiting Antibodies

• Published in: Clinical and Vaccine Immunology 2012-07, Vol.19 (7), p.1075-1082
• Main Authors: Day, Patricia M, Pang, Yuk-Ying S, Kines, Rhonda C, Thompson, Cynthia D, Lowy, Douglas R, Schiller, John T
• Format: Article
• Language: English
• Subjects: Amino acids; Animal models; Animals; Antibodies; Antibodies, Neutralizing - immunology; Antibodies, Viral - immunology; Antigens, Viral - immunology; Capsid Proteins - immunology; Clinical trials; Diagnostic Laboratory Immunology; Disease Models, Animal; Epitopes; Female; Fusion protein; Human papilloma virus 1; Human papillomavirus 16; Human papillomavirus 18; Immune serum; Immunization, Passive; Immunogenicity; Infection; Infectivity; Mice; Mice, Inbred BALB C; Neutralization Tests - methods; Oncogene Proteins, Viral - immunology; Papillomavirus Infections - prevention & control; Papillomavirus Vaccines - immunology; Rabbits; Sensitivity and Specificity; Vaccines
• ISSN: 1556-6811; 1556-679X; 1556-679X
• DOI: 10.1128/CVI.00139-12

Classifications Services CVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue CVI About CVI Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy CVI RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • [e-mail] Print ISSN: 1556-6811 Online ISSN: 1556-679X Copyright © 2014 by the American Society for Microbiology.   For an alternate route to CVI .asm.org, visit: CVI